How public bodies contract for research they cannot specify in advance
Research procurement has a structural problem: the buyer is purchasing an answer to a question, and if the answer were known the contract would be unnecessary. Public bodies deal with this by buying in phases. A feasibility or concept phase is awarded to several suppliers in parallel, each paid a modest fixed sum; a subset is then funded to prototype; a smaller subset again reaches demonstration. Each phase is a competition among the survivors of the last, so a bidder should read the notice for the phase structure and the progression criteria before pricing anything.
Intellectual property is the term that decides whether the contract is worth winning. Arrangements range from full assignment of results to the buyer, through a licence to the buyer with the supplier retaining ownership and the right to commercialise elsewhere, to background and foreground IP splits that must be catalogued before work starts. Development-focused schemes often deliberately leave ownership with the supplier so that a market can form around the result, while procurement of research for internal use tends toward assignment. The two produce very different bid economics.
Evaluation weights the proposal's scientific and technical merit, the team's record, and the credibility of the risk assessment, and it rewards candour about what might fail. Deliverables are reports, data and demonstrations rather than products, so acceptance criteria are written around defined technical readiness levels or measurable milestones. Where human participants, animals, personal data or dual-use technology are involved, ethical approval and export control clearance are conditions precedent with their own timetables, and they are a common cause of a project starting months after award.
This section describes how this category is bought generally, across the public buyers that publish it. The figures elsewhere on this page are measured for this market alone.
Who buys research & development in Slovenia?
GlobalGov holds 43 research & development records from 26 distinct buying organisations in Slovenia. The most frequent publishers are Kemijski Inštitut (5 records); Univerza v Mariboru (4 records); Kemijski inštitut (3 records); Univerza V Ljubljani, Medicinska Fakulteta (3 records); Univerzitetni klinični center Maribor (3 records); NACIONALNI INŠTITUT ZA BIOLOGIJO National Institute of Biology (2 records). Between them the 6 largest account for 47% of everything published, so buying here is spread across many separate authorities.
| Buying organisation | Records | Share |
|---|---|---|
| Kemijski Inštitut | 5 | 12% |
| Univerza v Mariboru | 4 | 9.3% |
| Kemijski inštitut | 3 | 7.0% |
| Univerza V Ljubljani, Medicinska Fakulteta | 3 | 7.0% |
| Univerzitetni klinični center Maribor | 3 | 7.0% |
| NACIONALNI INŠTITUT ZA BIOLOGIJO National Institute of Biology | 2 | 4.7% |
What are research & development contracts worth in Slovenia?
5 of the 43 records publish a contract value. The median is $177,045 and the largest single published value is $318,689. By size, 2 under $100k, 3 between $100k and $1M. The remaining 38 publish no value at all, so every figure here describes the priced subset only, and values are as stated by the buyer rather than as finally awarded.
| Contract size | Records | Share of priced |
|---|---|---|
| under $100k | 2 | 40% |
| between $100k and $1M | 3 | 60% |
| between $1M and $10M | 0 | 0.0% |
| above $10M | 0 | 0.0% |
How long do bidders get to respond to research & development tenders in Slovenia?
Across the 18 Slovenia research & development notices that publish both a publication date and a closing date, the median response window is 29 days. A quarter of them allowed 20 days or fewer and a quarter stayed open for more than 33. Short turnarounds are the exception rather than the rule here: only 1 (5.6%) closed within a fortnight of being published.
How often are research & development tenders published in Slovenia?
Slovenia published 20 notices in this category in the last twelve months. Over the last three years there were 21, spread across 23 separate months of activity since 29 March 2017. August is historically the busiest month. The most recent was published 8 September 2026.
How does Slovenia compare with other research & development markets?
Among the 35 countries where GlobalGov holds a comparable research & development market, Slovenia ranks 31st by number of records. The largest is Australia (13,059 records against 43 here). Within Slovenia itself, research & development is the 25th largest of the 28 procurement categories tracked here.
Where do the Slovenia research & development records on this page come from?
These 43 records are collected from 1 official source: TED (43). GlobalGov is an independent aggregator and is not affiliated with any of them; each record links back to the notice on its issuing portal. The set is rebuilt nightly, and the counts on this page were taken on 2026-10-01.
Open Research & Development tenders in Slovenia
Showing 5 of the 5 notices open in this category today. Openness uses the same definition as the Slovenia market page: active, not marked awarded, cancelled, closed or expired, and either closing in the future or published within the last 90 days with no stated closing date.
Slovenia – Laboratory, optical and precision equipments (excl. glasses) – Kompleta za določitev učinkovitosti in varnosti celične in genske terapije
Slovenia – Laboratory services – LABORATORIJSKE STORITVE
Slovenia – Laboratory, optical and precision equipments (excl. glasses) – Dinamični nabavni sistem za nabavo merilne opreme in učnih eksperimentov
Slovenia – Laboratory, optical and precision equipments (excl. glasses) – Pilotni sistem za pripravo polimernih materialov
Other procurement categories in Slovenia
Research & Development procurement in other markets
Never Miss a Slovenia Government Contract
Finding Slovenia tenders usually means a local portal, a local registration and someone who reads the language. Get an alert you can read when a new research & development opportunity is published there.
Start Free Trial